挂号20药费400多和挂号400药费100多,都是500多,你会选哪个?

2018-01-03 叶正松 江淮医学

这一奇怪现象个中原因其实一直是中国医改的目标靶心,遗憾的是,各级部门多举并措,这么多年这么多次的反复校调医改的准心,却始终不能一击命中问题核心。

12月29日,新浪微博名@大丹就是我吐槽:

为什么我宁愿选择私人诊所也不去公立医院?臭小子在年末旅行出发前三天半夜突发支气管炎,我的心都快凉了。连夜连晚在app上挂了卓正的号,但是也只挂到第二天下午的号,有点着急。第二天一大早忍不住抱他先去旁边的某公立医院找医生看了看,挂号费20块,雾化药三种,吃的药五种,加上验血一共下来500多。

不甘心,下午再带他去卓正看了看,挂号费400块,雾化药减为两种,吃药一种,会员打折合计500多块。用药两天,因为要出发去旅行,又带来卓正医生看了看,说小伙子康复很快,不用雾化了,只再需要吃那一种药几天。都是500多,你说我选哪个?

同样是医生,挂号费公立医院20,私立医院400。同样一名患者同样一种疾病,公立医院药费400多,私立医院100多,这的确令人匪夷所思又引人浮想联翩。让这位患儿家人不可思议的是,公私两家医院虽然挂号费用天壤之别,但总体费用却基本一样,都是500,区别就在于药品和治疗费用。

这一奇怪现象个中原因其实一直是中国医改的目标靶心,遗憾的是,各级部门多举并措,这么多年这么多次的反复校调医改的准心,却始终不能一击命中问题核心。为何?主要原因恐怕还是出在对医生这个职业人文解读和释义上。

不知从何时开始,我们的社会把医生推上了不食人间烟火的道德圣坛,在经济飞速发展的社会当下,医生成为了一提钱就伤道德的孔乙己。但凡在医疗实践活动中,只要医生涉及利益金钱,就如同背上耻辱的十字架,见不得阳光,上不了台面。只要涉及金钱利益,稍不得体,在得到与付出相辅相称的报酬同时也便站在了道德的最低点。这就无形中造成了整个诊疗过程中医患双方都变得拘谨扭捏,最终,医方不得不用最含蓄的一种方法去获取报酬和得利。

自古以来,中国人买东西喜欢买重的和大的,木头喜欢红木,手机喜欢全屏。从根子里不喜欢为无形的东西买单,比如知识产权和技术付费。全社会甚至包括某些医改专家,内心深处都无视或者漠视医生专业技术应该含有的含金量,而去强调医生看病不能收钱,只能收医德积分券。挂号诊断怎么能收钱呢?也不花一草一木一砖一瓦,要收,也只能象征的收。不仅挂号,甚至值班都不能发太高的值班费,最好只发医德积分券。这医德积分券可是一个好东西啊!医务人员积到一定分数,死了以后据说是可以去兑换上天堂的门票!

若问医生看病不挣钱怎么去圆中国梦,如何去过美好生活?自会有人告诉你,作为医生,以德为上,别那么功利,生活不止有眼前的苟且,还有医德积分券和天堂!实在太饿?那就干一碗“心不近佛不可为医”的心灵营养鸡汤吧。

其实,对发生在同人同病挂号20药费400多,和挂号400药费100多这一问题,答案就是童话中的那件皇帝新衣,人人都心知肚明,但是谁都不愿去说破,谁也不敢去正确回答。

打开天窗说亮话,对于医改,人人心中都有一个沉睡的改革家,只是,都不愿惊醒它,因为所谓理性,对一些人来说,就是一场痛苦而又漫长的失眠。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1446218, encodeId=f503144621825, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513222, encodeId=fc7a1513222cb, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275205, encodeId=eb862e520537, content=***, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35a52211252, createdName=120d6b16m40暂无昵称, createdTime=Thu Jan 04 00:22:48 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275143, encodeId=0db52e514342, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jan 03 22:21:06 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
    2018-01-05 bshuang
  2. [GetPortalCommentsPageByObjectIdResponse(id=1446218, encodeId=f503144621825, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513222, encodeId=fc7a1513222cb, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275205, encodeId=eb862e520537, content=***, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35a52211252, createdName=120d6b16m40暂无昵称, createdTime=Thu Jan 04 00:22:48 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275143, encodeId=0db52e514342, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jan 03 22:21:06 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1446218, encodeId=f503144621825, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513222, encodeId=fc7a1513222cb, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275205, encodeId=eb862e520537, content=***, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35a52211252, createdName=120d6b16m40暂无昵称, createdTime=Thu Jan 04 00:22:48 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275143, encodeId=0db52e514342, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jan 03 22:21:06 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
    2018-01-04 120d6b16m40暂无昵称

    ***

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1446218, encodeId=f503144621825, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513222, encodeId=fc7a1513222cb, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Fri Jan 05 13:15:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275205, encodeId=eb862e520537, content=***, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35a52211252, createdName=120d6b16m40暂无昵称, createdTime=Thu Jan 04 00:22:48 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275143, encodeId=0db52e514342, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jan 03 22:21:06 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
    2018-01-03 清风拂面

    很好的文章.谢谢分享

    0

相关资讯

改制6年后 这家三甲医院恢复“公立身份”

实行公立医院产权制度改革6年后,洛阳市中心医院恢复公立医院属性。

公立医院薪酬改革:部分涨薪超50%

按要求,公立医院将建立以公益性为导向的考核评价机制,做到多劳多得、优绩优酬。在岗位设置、收入分配、职称评定等方面,对编制内外人员统筹考虑。探索实行目标年薪制和协议薪酬。

从“公立”到“民营” 三甲医院为何再度改回公立

实行公立医院产权制度改革6年后,这家三级医院恢复了公立医院属性。12月21日,洛阳市妇女儿童医疗保健中心恢复公益属性产权转让签字仪式举行,该医院正式从民办非营利性医院回归公立医院序列,恢复公益属性。公开资料显示,洛阳市妇女儿童医疗保健中心(原洛阳市妇幼保健院)成立于1953年,下设洛阳市妇产医院、洛阳市儿童医院。是河南省市级医疗机构中率先成为集妇女儿童系统保健、疾病防治、教学科研为一体的三级妇幼专

青岛57所公立医院全面取消药品加成

青岛市深入推进医药卫生体制改革,医疗卫生事业蓬勃发展,57所公立医院全面取消药品加成,居民主要健康指标处于全国前列并达到中等发达国家水平。

安徽:公立医院动态编制来了,干不好走人!

满大街都在嚷嚷公立医院将取消事业编,但是却一直未真正落地,原因也较为复杂。但是这使得医院中职数、岗位都占满了,优秀人才进不来,医院成了一潭死水。

山东将控制公立综合医院数量 提高全科医生工资

为全面深化医药卫生体制改革,推进“健康山东”建设,12日,山东省人民政府印发《山东省“十三五”深化医药卫生体制改革规划》。《规划》中提出,按照“居民自愿、基层首诊、政策引导、创新机制”的原则,全面推进家庭医生签约服务,畅通上下转诊渠道,综合运用医疗、医保、医药、价格等手段,推动形成基层首诊、双向转诊、急慢分治、上下联动的就医新秩序,城市三级医院普通门诊就诊人次占医疗卫生机构总诊疗人次的比重明显